Virtus ETF Advisers LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$612,000
-16.5%
198,735
+10.6%
0.11%
-50.2%
Q4 2016$733,000
+15.3%
179,625
+79.5%
0.22%
-28.9%
Q3 2016$636,000
+34.7%
100,090
+14.4%
0.31%
-12.0%
Q2 2016$472,000
+78.8%
87,477
+177.0%
0.35%
-3.8%
Q1 2016$264,000
-0.4%
31,577
-5.9%
0.36%
-49.9%
Q4 2015$265,00033,5700.73%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders